Dje, what kind of news you are expecting about PBT2?
IMO the possibilities are:
1. Cardiac Light Chain Amyloidosis ( Diomede et al, 2017 ) related activity (phase 2, perhaps orphan disease application) 2. Co-operation with Queensland university about treating antibiotic-resistant infections ( human and food industry ) 3. Possible deal with the new big pharma co-operation to target development of new antibiotics 4. Covid-19 related news, PBT2 possibilities to kill viruses 5. patent-related news, related to the above issues 6. else
ATH Price at posting:
3.7¢ Sentiment: None Disclosure: Held
